Credit Suisse Ag Theravance Biopharma, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 115,418 shares of TBPH stock, worth $1.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

115,418

Previous 115,418 -0.0%

Holding current value

$1.14 Million

Previous $1.3 Million 20.2%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$8.58 - $11.4 $263,689 - $350,356	30,733 Added 36.29%	115,418 $1.3 Million
Q3 2023 Nov 13, 2023	SELL	$8.38 - $10.44 $22,651 - $28,219	-2,703 Reduced 3.09%	84,685 $730,000
Q2 2023 Aug 11, 2023	SELL	$10.16 - $11.92 $737,158 - $864,855	-72,555 Reduced 45.36%	87,388 $904,000
Q1 2023 May 10, 2023	BUY	$9.87 - $11.44 $589,416 - $683,173	59,718 Added 59.58%	159,943 $1.74 Million
Q4 2022 Feb 13, 2023	BUY	$9.65 - $11.34 $276,038 - $324,380	28,605 Added 39.94%	100,225 $1.12 Million
Q3 2022 Nov 10, 2022	BUY	$8.39 - $10.22 $3,204 - $3,904	382 Added 0.54%	71,620 $727,000
Q2 2022 Aug 12, 2022	BUY	$8.41 - $10.34 $49,534 - $60,902	5,890 Added 9.01%	71,238 $646,000
Q1 2022 May 16, 2022	SELL	$8.33 - $12.96 $7,605 - $11,832	-913 Reduced 1.38%	65,348 $624,000
Q4 2021 Feb 14, 2022	SELL	$7.42 - $11.05 $25,168 - $37,481	-3,392 Reduced 4.87%	66,261 $732,000
Q3 2021 Nov 12, 2021	BUY	$6.77 - $14.41 $46,922 - $99,875	6,931 Added 11.05%	69,653 $516,000
Q2 2021 Aug 16, 2021	BUY	$14.52 - $22.46 $201,653 - $311,924	13,888 Added 28.44%	62,722 $910,000
Q1 2021 May 14, 2021	SELL	$16.57 - $21.08 $226,760 - $288,479	-13,685 Reduced 21.89%	48,834 $996,000
Q4 2020 Feb 12, 2021	BUY	$14.89 - $20.16 $261,081 - $353,485	17,534 Added 38.98%	62,519 $1.11 Million
Q3 2020 Nov 13, 2020	SELL	$14.79 - $22.49 $1.01 Million - $1.53 Million	-68,067 Reduced 60.21%	44,985 $664,000
Q2 2020 Aug 12, 2020	SELL	$20.64 - $30.69 $571,170 - $849,284	-27,673 Reduced 19.66%	113,052 $2.37 Million
Q1 2020 May 13, 2020	SELL	$17.84 - $31.21 $132,301 - $231,453	-7,416 Reduced 5.01%	140,725 $3.25 Million
Q4 2019 Feb 12, 2020	BUY	$16.12 - $25.89 $982,933 - $1.58 Million	60,976 Added 69.95%	148,141 $3.84 Million
Q3 2019 Nov 12, 2019	BUY	$16.51 - $23.78 $1.08 Million - $1.55 Million	65,288 Added 298.43%	87,165 $1.7 Million
Q2 2019 Aug 14, 2019	SELL	$15.6 - $25.15 $333,871 - $538,260	-21,402 Reduced 49.45%	21,877 $357,000
Q1 2019 May 14, 2019	BUY	$22.57 - $28.15 $97,005 - $120,988	4,298 Added 11.03%	43,279 $981,000
Q4 2018 Feb 13, 2019	BUY	$22.52 - $35.07 $121,562 - $189,307	5,398 Added 16.07%	38,981 $997,000
Q3 2018 Nov 13, 2018	SELL	$22.83 - $32.67 $356,170 - $509,684	-15,601 Reduced 31.72%	33,583 $1.1 Million
Q2 2018 Aug 14, 2018	SELL	$22.06 - $25.52 $124,969 - $144,570	-5,665 Reduced 10.33%	49,184 $1.12 Million
Q1 2018 May 15, 2018	BUY	$23.37 - $29.71 $204,651 - $260,170	8,757 Added 19.0%	54,849 $1.33 Million
Q4 2017 Feb 14, 2018	SELL	$25.82 - $35.66 $338,732 - $467,823	-13,119 Reduced 22.16%	46,092 $1.29 Million
Q3 2017 Nov 14, 2017	BUY	$23.88 - $34.96 $596,379 - $873,091	24,974 Added 72.94%	59,211 $2.03 Million
Q2 2017 Aug 14, 2017	BUY	N/A	34,237	34,237 $1.36 Million

Others Institutions Holding TBPH

# of Institutions

122

Shares Held

47.3M

Call Options Held

200

Put Options Held

12.8K

View Full List

About Theravance Biopharma, Inc.

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $658M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

More about TBPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account